α2-HS Glycoprotein/Fetuin, a Transforming Growth Factor-β/Bone Morphogenetic Protein Antagonist, Regulates Postnatal Bone Growth and Remodeling - Wikidata - awgldk - TriplyDB

α2-HS Glycoprotein/Fetuin, a Transforming Growth Factor-β/Bone Morphogenetic Protein Antagonist, Regulates Postnatal Bone Growth and Remodeling

α2-HS Glycoprotein/Fetuin, a Transforming Growth Factor-β/Bone Morphogenetic Protein Antagonist, Regulates Postnatal Bone Growth and Remodeling

http://www.wikidata.org/entity/Q56999751

about

Tissue distribution and activity testing suggest a similar but not identical function of fetuin-B and fetuin-A Preclinical efficacy of cystatin C to target the oncogenic activity of transforming growth factor Beta in breast cancer Camurati-Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification The role of fetuin-A in mineral trafficking and deposition Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of colloidal calciprotein particles Identification of Fetuin-B as a member of a cystatin-like gene family on mouse chromosome 16 with tumor suppressor activity Systems biology approach reveals genome to phenome correlation in type 2 diabetes Amelogenesis imperfecta and other biomineralization defects in Fam20a and Fam20c null mice A hepatic protein, fetuin-A, occupies a protective role in lethal systemic inflammation Cerebrospinal fluid proteome profile in multiple sclerosis.Single nucleotide polymorphisms in bone turnover-related genes in Koreans: ethnic differences in linkage disequilibrium and haplotype.Marked defects in the expression and glycosylation of alpha2-HS glycoprotein/fetuin-A in plasma from neonates with intrauterine growth restriction: proteomics screening and potential clinical implications.Peripheral administration of fetuin-A attenuates early cerebral ischemic injury in rats.Intraperitoneal administration of fetuin-A attenuates D-galactosamine/lipopolysaccharide-induced liver failure in mouse Fetuin-A, a hepatocyte-specific protein that binds Plasmodium berghei thrombospondin-related adhesive protein: a potential role in infectivity.Accelerated growth plate mineralization and foreshortened proximal limb bones in fetuin-A knockout mice.Serum immune-related proteins are differentially expressed during hibernation in the American black bear Protective role of α2HS-glycoprotein in HBV-associated liver failure.Discovery and horizontal follow-up of an autoantibody signature in human prostate cancer.The Sox2 high mobility group transcription factor inhibits mature osteoblast function in transgenic mice Proteomic analysis of cerebrospinal fluid in canine cervical spondylomyelopathy.Anti-inflammatory role of fetuin-A in injury and infection.The inflammation-induced down-regulation of plasma Fetuin-A (alpha2HS-Glycoprotein) in liver results from the loss of interaction between long C/EBP isoforms at two neighbouring binding sites Role of cystatins in tumor neovascularization.Arterial calcification and stiffness in chronic kidney disease.Recent advances in protein profiling of tissues and tissue fluids.Relation of serum fetuin-A levels to coronary artery calcium in African-American patients on chronic hemodialysis.Proteomic profiling in early venous stenosis formation in a porcine model of hemodialysis graft Prox1 ablation in hepatic progenitors causes defective hepatocyte specification and increases biliary cell commitment.The extracellular regulation of bone morphogenetic protein signaling.α2-Heremans-schmid glycoprotein (fetuin A) downregulation and its utility in inflammatory bowel disease.Review article: non-alcoholic fatty liver disease and osteoporosis--clinical and molecular crosstalk.Impact of matrix metalloproteinases on inhibition of mineralization by fetuin.Role of fetuin-A in atherosclerosis associated with diabetic patients.The role of fetuin-A in physiological and pathological mineralization.Effect of Exogenous Fetuin-A on TGF-β/Smad Signaling in Hepatic Stellate Cells.The serum protein fetuin-B is involved in the development of acute myocardial infarction.The farnesoid X receptor induces fetuin-B gene expression in human hepatocytes.Cardioprotective effects of ω -3 PUFAs in chronic kidney disease.

P2860

Q24530543-B34D0E64-1127-4227-92EE-18D2DBF1B136 Q24648403-9D939F73-93A0-4C8F-B810-3FB7516112C4 Q24655306-9F8CF50F-D851-40B2-99F0-52DBFC627578 Q24679476-141D77C3-D6F6-4432-BACA-877A4992612C Q27021447-F7C4E15A-BD74-4FAE-AE16-91250D30A9FB Q28205960-00B6B01C-4A7B-4209-A8F9-8B25821253A2 Q28289164-70E1C6ED-17C2-4DBB-AD53-729E06F5A937 Q28484866-F3F6C9CD-1282-4886-9ABA-999CB0656282 Q28593754-A507AFBE-8AE4-4601-AFE9-873714A76076 Q28742970-24418421-CF9F-43C0-8A3B-71CC4E964EE5 Q33299647-7086980A-FA23-4023-B54C-6338C9C87D25 Q33307072-D3B9C52C-75B5-4E61-ADD4-E12AFE8FCE39 Q33309151-C0B410BA-73A3-4396-9178-12669F062E85 Q33814947-9891797E-1479-43B5-A6C9-3FC6452210D3 Q33990872-5ABE47D9-CB0B-4D77-9BCE-245B25D8D43A Q34034163-9DAF6363-35E9-4671-9CF6-836B780425A9 Q34455206-9BB54FD0-EC48-4545-98ED-5C9D7DE3CFA8 Q34793994-213A557B-E8DD-44DE-AAF7-EF4355AA386E Q35091813-761512F1-74B1-48B9-8930-FD6D14566787 Q35134650-70727459-F721-4BE5-AC52-DC4F68A1289D Q35196457-A41F6573-C18C-41AA-8741-48E594EA35B1 Q35672528-9ADBE513-B909-4460-82EE-C9B640403B76 Q35951563-7E735BAC-BCE8-4B9B-ACA9-2A16DAE0209A Q36372808-61E72EE6-D3F6-4CEC-B7C2-5D6F8295E199 Q36429583-54B242BF-080A-4E02-AC67-2F1B13854131 Q36854161-74272CC9-2558-470B-81F7-CE2149BF53B6 Q36913050-103D8D5D-BBDA-461D-8D14-7799D3D834F0 Q37073515-9224CD12-8B34-4E2B-AB57-812291B058EE Q37184382-79A1412D-6D58-40BF-8C97-505A251FF105 Q37507607-BC67CB30-5AD7-4912-B0A8-EE675B3F1CA1 Q37621158-52547773-9C58-4A34-B639-5AE89157FD3D Q37624490-6264ADEA-9545-412A-8C69-6E26D5A349E4 Q38021479-7DF3A324-9FD6-4273-962F-2DDF265FAC08 Q38051442-CC70D21C-8832-4588-A45A-17B6D92D0204 Q38059247-3EBEAA69-51CA-42CB-93E5-C0778DCC2E65 Q38070658-DC3684DC-675C-4586-AF7C-83627151B206 Q38725540-341D4418-159E-4338-ABC7-3D1004226C05 Q38910796-290DD667-0836-4647-B00C-3C05D31519BD Q40102152-42878612-5F4D-4FA2-AC20-C0AC54B6617C Q40196363-173E83AA-3C3C-47DC-9472-972AC41B9F5D

P2860

α2-HS Glycoprotein/Fetuin, a Transforming Growth Factor-β/Bone Morphogenetic Protein Antagonist, Regulates Postnatal Bone Growth and Remodeling

http://www.wikidata.org/entity/Q56999751

description

article publié dans la revue scientifique Journal of Biological Chemistry

@fr

im März 2002 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published in Journal of Biological Chemistry

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в березні 2002

@uk

name

α2-HS Glycoprotein/Fetuin, a T ...... tal Bone Growth and Remodeling

@en

α2-HS Glycoprotein/Fetuin, a T ...... tal Bone Growth and Remodeling

@nl

type

label

α2-HS Glycoprotein/Fetuin, a T ...... tal Bone Growth and Remodeling

@en

α2-HS Glycoprotein/Fetuin, a T ...... tal Bone Growth and Remodeling

@nl

prefLabel

α2-HS Glycoprotein/Fetuin, a T ...... tal Bone Growth and Remodeling

@en

α2-HS Glycoprotein/Fetuin, a T ...... tal Bone Growth and Remodeling

@nl

P1433

Q56999751-083B982F-D674-4EE7-931C-0E09CF199D1D

P1476

Q56999751-38CECB57-E76F-463D-A93C-8FF8235280B7

P2093

Q56999751-0B1B8F59-87BF-48BA-8F69-B129C5AD0C95

Q56999751-26AC0680-26E0-4A8F-BDC2-3F5B434EA5BC

Q56999751-31F382AB-E62F-4602-9202-DA6D425E58B5

Q56999751-4910D3B9-6254-44C4-BF89-AB3280B3BB91

Q56999751-612C9CE4-4DFE-4BD0-A274-3A865B6E5357

Q56999751-6734DE38-CAEB-4015-B6AC-B824F512FC52

Q56999751-96B0EC3C-4C51-4460-8B84-517CD542B57F

Q56999751-CC6040BF-ADB5-41E0-BCA4-CC7930ECFEDE

Q56999751-D4130288-494F-42E5-9341-EFE254DA0DB6

Q56999751-D6E0295E-A5C5-4EB1-A713-4284637A520A

P2860

Q56999751-14F9D5B3-6B23-4C3D-BB70-2B1DB08F0B97

Q56999751-16852CBA-C1BA-444C-94DB-805B2E13F56D

Q56999751-1BB55FF9-76C2-4C44-8BE2-E8B5AD419BB4

Q56999751-1BC37A13-C519-4BF7-8144-2AD328471D4F

Q56999751-23A090C5-A04B-4837-81D6-AF200A3FCEBD

Q56999751-32F93A3F-A029-40E7-BED1-7D310F09C36D

Q56999751-35AD42F6-114B-4B28-A239-B982BBC2934D

Q56999751-35AEF129-7551-4143-9D45-9ED716C9EFE4

Q56999751-3E935C65-1DC3-4E42-980F-BE8BDC281B1D

Q56999751-47C6C005-2D2E-43A5-9C1B-B6A4ACDC6123

P304

Q56999751-78C926B0-FE02-466C-9C31-9EBF7C271B93

P31

Q56999751-64A14C39-D934-4C82-A5C5-3E078DD2675A

P356

Q56999751-92CE9A65-3EAF-4E1C-84DB-1288874DB28F

P407

Q56999751-FB5A4634-8F1A-40B2-A923-B2609C68FFA1

P433

Q56999751-3077E722-D977-47DA-ABC3-C547D78DB8FF

P478

Q56999751-2BB82DE5-6B04-4A71-9F1D-2E89C292A8DA

P50

Q56999751-493D5291-CA9D-4F24-BADA-AADE1A9B2E23

P577

Q56999751-38D0C984-876C-4355-9742-9BC5BF14AE17

P698

Q56999751-5A494F60-ADDC-491D-A78F-CEEB4BBE709A

P921

Q56999751-0BB73521-E86F-4CEC-A5ED-88A5E13C689B

P356

P1433

Journal of Biological Chemistry

P1476

α2-HS Glycoprotein/Fetuin, a T ...... tal Bone Growth and Remodeling

@en

P2093

Balram Sukhu

http://www.w3.org/2001/XMLSchema#string

Cameron Clokie

http://www.w3.org/2001/XMLSchema#string

Carol J. Swallow

http://www.w3.org/2001/XMLSchema#string

Danmei Liu

http://www.w3.org/2001/XMLSchema#string

Emily A. Partridge

http://www.w3.org/2001/XMLSchema#string

Howard C. Tenenbaum

http://www.w3.org/2001/XMLSchema#string

James W. Dennis

http://www.w3.org/2001/XMLSchema#string

Judy Pawling

http://www.w3.org/2001/XMLSchema#string

Marc D. Grynpas

http://www.w3.org/2001/XMLSchema#string

Melanie Szweras

http://www.w3.org/2001/XMLSchema#string

P2860

Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta

Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation

Betaglycan can act as a dual modulator of TGF-beta access to signaling receptors: mapping of ligand binding and GAG attachment sites

Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease

Noggin, cartilage morphogenesis, and joint formation in the mammalian skeleton

Fetuin/alpha2-HS glycoprotein is a transforming growth factor-beta type II receptor mimic and cytokine antagonist

Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice

Negative regulation of transforming growth factor-beta by the proteoglycan decorin

Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response

Bone matrix proteins in osteogenesis and remodelling in the neonatal rat mandible as studied by immunolocalization of osteopontin, bone sialoprotein, alpha 2HS-glycoprotein and alkaline phosphatase

P304

19991-19997

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1074/JBC.M112234200

http://www.w3.org/2001/XMLSchema#string

P407

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

277

http://www.w3.org/2001/XMLSchema#string

P50

Willi Jahnen-Dechent

P577

2002-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11901155

http://www.w3.org/2001/XMLSchema#string

P921